Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Which Passive Funds Are Best For Retirement 2024 highlights top low-cost, diversified options that fit long-term retirement goals.
23,976 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Analysts issued a fresh round of high-conviction calls Wednesday, spotlighting Arm Holdings, BorgWarner, GM, Mondelez...
FuboTV’s reverse split failed to spark a lasting rally, with shares sliding as the company reports rising revenue but...
Chewy just popped. stock momentum followed a better-than-expected 2026 outlook, even as Q4 growth stayed modest. This...
A fintech stock surged in recent years, then faced a pullback during down weeks. This article outlines a disciplined ...
Tower Semiconductor is navigating a critical inflection point as it scales SiPho production and expands in Japan, wit...
Netflix unveiled a broad price increase across every U.S. tier, with an 11% average lift. JPMorgan says the move coul...
Palantir faces a pivotal moment as 2025 results reinforce growth in AI-related revenue, yet lofty valuations keep inv...
Workers say their benefits aren’t safety nets but leverage points used to keep them in place. This timely report expl...
Rem’s Mortgage REIT Portfolio surged 19% over the past year as the Fed signaled a slower stance on rates, lifting inc...
Super Micro Computer posted a margin-led earnings surprise that beat expectations and lifted full-year guidance, prom...
As streaming shifts accelerate, FuboTV's 2026 earnings outlook hinges on subscriber growth, ad revenue, and content c...